Remix Therapeutics · 13 hours ago
Associate Director, Strategy & Business Development
Watertown, MA
Full-time
Onsite
Lead/Staff, Director/Executive
$182K/yr - $223K/yr
3+ years expRemix Therapeutics is a biotechnology company focused on transforming patients’ lives through modulation of RNA processing. They are seeking an Associate Director, Strategy & Business Development to support corporate partnering activities and investor communications, playing a key role in shaping strategic opportunities and advancing partnerships.
BiotechnologyHealth CareMedicalTherapeutics
No H1B
Responsibilities
Support the Chief Business Officer in building and managing the business development pipeline aligned with company strategy
Conduct scientific, commercial, and competitive analyses on market trends to inform priorities and recommendations
Develop clear, concise materials for internal decision‑making, including opportunity overviews, business cases, and presentations for senior leadership and the Board
Coordinate cross‑functional due diligence with internal Remix functions
Maintain tracking of business development activities and prepare concise updates and dashboards for leadership
Support development and refinement of investor communications, including corporate presentations and supporting materials
Assist with fundraising processes, including organizing and managing due diligence materials and data rooms
Help manage relationships with current and prospective investors through meeting preparation, follow‑up, and ongoing updates
Maintain internal materials related to company strategy, pipeline, and milestones to ensure clear and consistent messaging
Qualification
Required
Advanced degree in a life science discipline (e.g., PhD, PharmD, MD, or MS) strongly preferred; MBA or formal business/finance training a plus
3–5 years of relevant experience in biotech strategy and business development, life sciences consulting, or equity research focused on biopharma
Demonstrated ability to interpret scientific and clinical data and translate it into clear strategic and commercial implications
Excellent slide‑writing and communication skills; able to distill complex topics into concise narratives for senior stakeholders
Ability to work independently in a fast‑paced, entrepreneurial environment, manage multiple opportunities in parallel, and drive projects forward with limited oversight
Flexible and collaborative working style with experience partnering across scientific and business functions
Authorized to work in the United States
Preferred
Background in oncology preferred
Benefits
Bonus
Equity
Benefits
Company
Remix Therapeutics
Remix Therapeutics is a biotechnology company that is working on developing small molecule medicines.
51-200 employees
Funding
Current Stage
Growth StageTotal Funding
$211MKey Investors
The Column GroupSurveyor CapitalForesite Capital
2024-01-03Series Unknown· $60M
2022-05-17Series B· $70M
2020-12-08Series A· $65M
Leadership Team
Peter Smith
Co-Founder, President and CEO
Heather Wasserman
COO/CBO
Recent News
2026-01-11
2026-01-06
Remix Therapeutics
2025-11-03
Company data provided by crunchbase